Are IBD drugs safe in pregnancy? large french study investigates
NCT ID NCT03134508
First seen Mar 14, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study analyzed data from over 8,700 pregnant women with inflammatory bowel disease (Crohn's or ulcerative colitis) to see how well doctors follow guidelines when prescribing antiTNFα drugs and whether the benefits outweigh the risks for both mother and baby. Researchers looked at complications related to the disease, treatment, and pregnancy, as well as infections in babies during their first year. The goal is to provide clearer evidence for safer treatment decisions during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu de Dijon
Dijon, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antiTNFα (anti-tumor necrosis factor alpha) drugs
What this could lead to
If successful, this could help doctors make safer decisions about using antiTNFα drugs during pregnancy in women with inflammatory bowel disease.
What could go wrong
This is an observational study using existing hospital records, not a controlled trial. It can show associations but cannot prove cause and effect. Results may not apply to other countries or populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.